John & Marilyn Bishop Charitable Foundation Endowed Chair  and Director of Alzheimer’s Disease Research

John & Marilyn Bishop Charitable Foundation Endowed Chair and Director of Alzheimer’s Disease Research

Beaumont Research Institute (BRI)

Royal Oak, MI, United States

John & Marilyn Bishop Charitable Foundation Endowed Chair
and Director of Alzheimer’s Disease Research
Beaumont Research Institute
Beaumont Health
Royal Oak, Michigan

Beaumont Research Institute (BRI), the research hub of Beaumont Health and research partner with Oakland University William Beaumont School of Medicine (OUWB), seeks applications and nominations for the inaugural John & Marilyn Bishop Charitable Foundation Endowed Chair and Director of Alzheimer’s Disease Research (Bishop Chair). This is a compelling opportunity for an experienced investigator to lead the design and implementation of an expanding, multimodal and cross-disciplinary research program at an innovative institution.

A growing number of adults are facing the prospect of a future with Alzheimer’s disease (AD). Among the six leading causes of death in the United States, AD is the only one that is becoming increasingly prevalent. As many as 5.1 million people are affected by AD today; the prevalence is expected to reach 16 million by 2050. In light of these facts, the Bishop Chair was created to expand current research efforts in AD at BRI while building the framework and infrastructure to initiate new avenues of study.

Beaumont Health is Michigan’s largest health care system, as assessed by inpatient admissions and net patient revenue, and has a strategic partnership with Oakland University William Beaumont School of Medicine. This not-for-profit organization was formed in 2014 by the merger of three legacy health systems to provide patients with the benefit of greater access to extraordinary, compassionate care within Southeast Michigan. The health system consists of eight hospitals with 3,381 beds, 168 outpatient sites and nearly 5,000 affiliated physicians. In 2017, the organization had $4.4 billion in revenue with approximately 175,000 inpatient admissions, 574,000 emergency visits, and 5,100 patients with a diagnosis of AD.

In 2017, research expenditures at BRI totaled $36.9 million. Research strengths at BRI and OUWB include cardiology, geriatrics, infectious disease, medical education, neuroscience, obstetrics & gynecology, oncology, orthopedics, radiation oncology, and urology, with a commitment by both institutions to develop a nationally recognized program in population/community health that transcends departmental lines. The Bishop Chair will work with top investigators from these disciplines to set program goals and will recruit additional clinicians and scientists to expand strategic AD research initiatives and to create a unified research focus moving forward.

Employed by BRI and Beaumont Health, the successful candidate for the Bishop Chair will have an MD, DO, and/or PhD degree (or equivalent) with academic credentials qualifying for appointment as an associate or full professor at OUWB. Salary and startup will be commensurate with credentials. In addition to an appointment in the Department of Foundational Medical Studies at OUWB and a position on the OUWB Council of Program Chairs and Directors, individuals with an MD or DO will have a joint appointment in the relevant clinical department at Beaumont Hospital, Royal Oak. The Bishop Chair must possess exceptional communication and collaborative leadership skills together with a demonstrated track record of external funding and scholarly publications.

BRI has engaged Isaacson, Miller, a national executive search firm, to assist with this important recruitment. Applications, nominations, and inquiries may be submitted to Jamie Sands and Laura Mariani at: www.imsearch.com/6773

Beaumont Health is an Equal Opportunity/Affirmative Action Employer. Women and those from diverse racial, ethnic and cultural backgrounds are encouraged to apply.

Please apply via recruiter’s website.

Favorite